Related Experiment Video
Updated: Jul 19, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Pseudohypoparathyroidism type Ia and growth hormone deficiency. Growth hormone releasing hormone receptor defect?
Fotini Psychou1, Polyxeni Nicolaidou, Helen Georgouli
1First Pediatric Department, Athens University Medical School, Aghia Sophia Children's Hospital, Athens, Greece.
Insights
This study details a boy with pseudohypoparathyroidism (PHP) and hypothyroidism who exhibited developmental delay and low growth hormone (GH). He showed no response to growth hormone-releasing hormone (GHRH), suggesting a potential GHRH receptor defect.
Area of Science:
- Pediatric Endocrinology
- Genetics
- Metabolic Disorders
Background:
- Pseudohypoparathyroidism (PHP) is a genetic disorder characterized by resistance to parathyroid hormone (PTH).
- Albright's hereditary osteodystrophy (AHO) presents with characteristic physical features and biochemical abnormalities.
- Combined endocrine deficiencies can occur in PHP, impacting growth and development.
Purpose of the Study:
- To report a case of a boy with pseudohypoparathyroidism, hypothyroidism, and impaired growth hormone (GH) secretion.
- To investigate the response to growth hormone-releasing hormone (GHRH) stimulation in this patient.
- To explore potential receptor defects contributing to the observed endocrine dysfunction.
Main Methods:
- Clinical presentation and physical examination for AHO features.
- Biochemical assays for serum calcium, phosphate, PTH, thyroxine (T4), and thyroid-stimulating hormone (TSH).
- Provocative testing for GH secretion using Glucagon, L-Dopa, and GHRH; Insulin-like Growth Factor I (IGFI) measurement before and after GH administration.
Main Results:
- The patient displayed features of AHO and biochemical evidence of PHP (hypocalcemia, hyperphosphatemia, elevated PTH) with no response to PTH.
- Hypothyroidism was confirmed with low T4 and high TSH.
- Growth hormone (GH) levels remained low (<2.5 microg/L) after Glucagon/L-Dopa and GHRH stimulation (<0.2 microg/L), but responded to exogenous GH administration.
Conclusions:
- The patient has confirmed PTH and TSH receptor defects.
- The lack of GH response to GHRH suggests a possible GHRH receptor defect.
- This case highlights the complex endocrine interplay and potential for multiple receptor defects in PHP.
Abstract:
We report a boy with pseudohypoparathyroidism (PHP), hypothyroidism and low growth hormone (GH) values with no response to growth hormone releasing hormone (GHRH). He presented at age 17 mo because of developmental delay. He had the typical features (short stature, obesity, round face, brachydactyly) of Albright's hereditary osteodystrophy (AHO) and the biochemical profile of PHP; low serum calcium and high phosphate, raised parathormone (PTH) values and lack of response of urinary phosphate and cyclic AMP to PTH administration. The serum total thyroxine value (T4) was 37.32 nmol/L and the thyroid stimulating hormone (TSH) 29 mU/L. Peak GH values during two provocative tests (Glucagon, L-Dopa) were <2.5 microg/L and <1.7 microg/L, respectively, while following GHRH administration the maximum GH value was 0.2 microg/L. The IGFI value was 65 ng/ml and rose to 253 ng/ml after GH administration for three days. This boy had PTH and TSH receptor defect and we speculate that he also has GHRH receptor defect.
More Related Videos
Related Concept Videos
Hypothyroidism II: Pathophysiology
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Type I Diabetes I: Introduction
Cushing Syndrome II: Pathophysiology
Graves Disease II: Pathophysiology

